The Lancet RheumatologyVolume 2, Issue 10, October 2020, Page e592NewsCOVACTA trial raises questions about tocilizumab's benefit in COVID-19Author links open overlay panelBryant FurlowShow moreShareCitehttps://doi.org/10.1016/S2665-9913(20)30313-1Get rights and contentPrevious article in issueNext article in issueRecommended articlesCited by (0)View Abstract© 2020 Elsevier Ltd. All rights reserved.